558 related articles for article (PubMed ID: 25159276)
21. Nanoparticle-mediated delivery of non-viral gene editing technology to the brain.
Williams L; Larsen J
Prog Neurobiol; 2024 Jan; 232():102547. PubMed ID: 38042249
[TBL] [Abstract][Full Text] [Related]
22. Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System.
Mendonça MCP; Kont A; Aburto MR; Cryan JF; O'Driscoll CM
Mol Pharm; 2021 Apr; 18(4):1491-1506. PubMed ID: 33734715
[TBL] [Abstract][Full Text] [Related]
23. A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer's Disease.
Arora S; Sharma D; Layek B; Singh J
Mol Pharm; 2021 Dec; 18(12):4237-4255. PubMed ID: 34705472
[TBL] [Abstract][Full Text] [Related]
24. Non-viral nucleic acid delivery to the central nervous system and brain tumors.
Wang S; Huang R
J Gene Med; 2019 Jul; 21(7):e3091. PubMed ID: 30980444
[TBL] [Abstract][Full Text] [Related]
25. A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System.
Bellizzi A; Ahye N; Jalagadugula G; Wollebo HS
J Neuroimmune Pharmacol; 2019 Dec; 14(4):578-594. PubMed ID: 31512166
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
27. Delivery of siRNA into the blood-brain barrier: recent advances and future perspective.
Kuwahara H; Yokota T
Ther Deliv; 2012 Apr; 3(4):417-20. PubMed ID: 22834073
[No Abstract] [Full Text] [Related]
28. Use of gene therapy in central nervous system repair.
Tinsley R; Eriksson P
Acta Neurol Scand; 2004 Jan; 109(1):1-8. PubMed ID: 14653844
[TBL] [Abstract][Full Text] [Related]
29. Delivery Approaches for Therapeutic Genome Editing and Challenges.
Ates I; Rathbone T; Stuart C; Bridges PH; Cottle RN
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32977396
[TBL] [Abstract][Full Text] [Related]
30. Prospects for gene therapy in pediatric neurosurgery.
Kaplitt MG; Darakchiev B; During MJ
Pediatr Neurosurg; 1998 Jan; 28(1):3-14. PubMed ID: 9693323
[TBL] [Abstract][Full Text] [Related]
31. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
[TBL] [Abstract][Full Text] [Related]
32. Translational considerations for CNS gene therapy.
Ryan DA; Federoff HJ
Expert Opin Biol Ther; 2007 Mar; 7(3):305-18. PubMed ID: 17309323
[TBL] [Abstract][Full Text] [Related]
33. Invasive drug delivery.
Blömer U; Ganser A; Scherr M
Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
[TBL] [Abstract][Full Text] [Related]
34. AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges.
Kang L; Jin S; Wang J; Lv Z; Xin C; Tan C; Zhao M; Wang L; Liu J
J Control Release; 2023 Mar; 355():458-473. PubMed ID: 36736907
[TBL] [Abstract][Full Text] [Related]
35. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.
Ul Ain Q; Chung JY; Kim YH
J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825
[TBL] [Abstract][Full Text] [Related]
36. Viral vector-mediated gene transfer for CNS disease.
Snyder BR; Boulis NM; Federici T
Expert Opin Biol Ther; 2010 Mar; 10(3):381-94. PubMed ID: 20132059
[TBL] [Abstract][Full Text] [Related]
37. Genome-editing Technologies for Gene and Cell Therapy.
Maeder ML; Gersbach CA
Mol Ther; 2016 Mar; 24(3):430-46. PubMed ID: 26755333
[TBL] [Abstract][Full Text] [Related]
38.
Marcó S; Haurigot V; Bosch F
Hum Gene Ther; 2019 Oct; 30(10):1211-1221. PubMed ID: 31482754
[TBL] [Abstract][Full Text] [Related]
39. Brain Angiogenesis Induced by Nonviral Gene Therapy with Potential Therapeutic Benefits for Central Nervous System Diseases.
Gallego I; Villate-Beitia I; Soto-Sánchez C; Menéndez M; Grijalvo S; Eritja R; Martínez-Navarrete G; Humphreys L; López-Méndez T; Puras G; Fernández E; Pedraz JL
Mol Pharm; 2020 Jun; 17(6):1848-1858. PubMed ID: 32293897
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy-mediated modulation of immune processes in the central nervous system.
Furlan R; Pluchino S; Martino G
Curr Pharm Des; 2003; 9(24):2002-8. PubMed ID: 12871186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
